These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34511892)

  • 1. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.
    Wu YK; Su WL; Yang MC; Chen SY; Wu CW; Lan CC
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2475-2485. PubMed ID: 34511892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readmission Due to Exacerbation of COPD: Associated Factors.
    Cerezo Lajas A; Gutiérrez González E; Llorente Parrado C; Puente Maestu L; de Miguel-Díez J
    Lung; 2018 Apr; 196(2):185-193. PubMed ID: 29445935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
    Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
    Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
    Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
    Blasi F; Neri L; Centanni S; Falcone F; Di Maria G
    COPD; 2017 Feb; 14(1):15-22. PubMed ID: 27824270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
    Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
    Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of roflumilast in the COPD frequent exacerbator phenotype.
    Wedzicha JA; Rabe KF; Martinez FJ; Bredenbröker D; Brose M; Goehring UM; Calverley PMA
    Chest; 2013 May; 143(5):1302-1311. PubMed ID: 23117188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis.
    Yoon HY; Park SY; Lee CH; Byun MK; Na JO; Lee JS; Lee WY; Yoo KH; Jung KS; Lee JH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1389-1397. PubMed ID: 31388298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
    Uslu B; Gülsen A; Arpinar Yigitbas B
    Tanaffos; 2022 Mar; 21(3):307-316. PubMed ID: 37025319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single exacerbation on decline in lung function in COPD.
    Halpin DMG; Decramer M; Celli BR; Mueller A; Metzdorf N; Tashkin DP
    Respir Med; 2017 Jul; 128():85-91. PubMed ID: 28610675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
    Zhao D; Abbasi A; Rossiter HB; Su X; Liu H; Pi Y; Sang L; Zhong W; Yang Q; Guo X; Zhou Y; Li T; Casaburi R; Zhang N
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2379-2388. PubMed ID: 33061355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting exacerbations in COPD in the Danish general population.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.
    Wedzicha JA; Brill SE; Allinson JP; Donaldson GC
    BMC Med; 2013 Aug; 11():181. PubMed ID: 23945277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.